Innate Pharma S.A.
ENXTPAIPH short utilization hits 93.73%, near the 52-week high of 96.85%, signaling heavy borrowing demand for the biotech stock.
Snapshot as of 29 Jun 2026
No long-form analysis yet for IPH. Pulse alerts and the live data picture are available on ORTEX.
Open IPH on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IPH — free to start on ORTEX.
Sign up for free →Open IPH on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live IPH data →